| abstract |
The present invention provides compounds of formula (I), including tautomers, isolated enantiomers, diastereoisomers, solvates, metabolites, salts and pharmaceutically acceptable prodrugs. (I) Also provided are methods of using the compounds of the invention as AKT protein kinase inhibitors and for the treatment of proliferative disorders such as cancer. |